Glycopep glycopep.com


Public lists: Pharma Startups (4732)

Glycopep is engaged in the synthesis and development of unique chemicals and resin products to support drug discovery. Glycopep is providing custom synthesis to academic institutions and pharmaceutical/biotech companies.

Glycopep is engaged in the synthesis and development of unique chemicals and resin products to support drug discovery. Glycopep is providing custom synthesis to academic institutions and pharmaceutical/biotech companies.

Company (Alive / Active)

Phone:

Fax:

2201 West Campbell Park Dr Ste 38
Chicago, 60612
Illinois, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Glycopep $0M Nov 30, 2018
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Glycopep Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Melinta Therapeutics

New Haven, Connecticut, United States
IPO / Went publicMelinta Therapeutics, formerly Rib-X Pharmaceuticals, is dedicated to the discovery, development and commercialization of groundbreaking antibiotics to overcome drug-resistant, life-threatening infections. The need for new therapies for drug-resistant infections is widely recognized as one of the most serious public health issues facing the world today. To meet this need, Melinta Therapeutics is rapidly progressing its late-stage investigational antibiotic, delafloxacin, which is currently in Ph...Show allLogin to see details

Infinity Pharmaceuticals

Cambridge, Massachusetts, United States
IPO / Went publicInfinity Pharmaceuticals is a drug discovery company that is developing and integrating approaches and capabilities in synthetic chemistry, chemical genetics, informatics, and biological screening.Login to see details
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)